Immediate Impact
32 by Nobel laureates 37 from Science/Nature 73 standout
Citing Papers
Ligand-Targeted Drug Delivery
2017 Standout
Antibody Therapeutics in Cancer
2013 StandoutScience
Works of David A. Eberhard being referenced
Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib
2005 Standout
Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor.
2000
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| David A. Eberhard | 2231 | 2434 | 2081 | 50 | 5.2k | |
| Douglas W. Ball | 2661 | 3334 | 1054 | 92 | 7.0k | |
| Oriol Casanovas | 2303 | 3784 | 889 | 70 | 6.1k | |
| David W. Yandell | 3088 | 3869 | 748 | 67 | 6.9k | |
| Kelli Montgomery | 2127 | 3228 | 2321 | 64 | 7.4k | |
| Angela Greco | 1841 | 3161 | 1249 | 118 | 6.2k | |
| Stephen R. Wedge | 2549 | 3588 | 1563 | 101 | 6.9k | |
| Zhen Fan | 3015 | 2492 | 1424 | 70 | 5.5k | |
| Karen Cichowski | 1460 | 3502 | 1251 | 58 | 6.4k | |
| Francesca Carlomagno | 2360 | 2892 | 878 | 89 | 6.1k | |
| Dora Dias‐Santagata | 3398 | 3183 | 2155 | 112 | 7.6k |
All Works
Loading papers...